AdAlta to present lead product AD-214 at MPGPCR 2023 pharmacology conference

AdAlta Ltd (ASX:1AD) has been selected for an extended oral presentation at the 11th Molecular Pharmacology of GPCRs meeting to be held in Melbourne from...

Related Keywords

Monash ,South Australia ,Australia ,Melbourne ,Victoria ,Jason Lynch ,Adalta Ltd ,Monash Institute Of Pharmaceutical Sciences ,Molecular Pharmacology ,Monash Institute ,Idiopathic Pulmonary Fibrosis ,